TECX
Tectonic Therapeutic, Inc.
Price Chart
Latest Quote
$32.60
+1.95 (+6.36%)
Current Price
| Previous Close | $30.65 |
| Open | $30.18 |
| Day High | $32.75 |
| Day Low | $30.18 |
| Volume | 277,608 |
Stock Information
| Shares Outstanding | 18.87M |
| Total Debt | $4.63M |
| Cash Equivalents | $236.89M |
| Net Income | $-83.49M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $615.14M |
| EPS (TTM) | $-4.46 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $382.87M |
| Income | $-83.49M |
| Book/sh | $12.24 |
| Cash/sh | $12.55 |
| Employees | 60 |
Financial Ratios
| Quick Ratio | 18.28 |
| Current Ratio | 18.51 |
| Debt/Eq | 2.01 |
Returns & Margins
| ROA | -20.72% |
| ROE | -31.42% |
Ownership
| Insider Ownership | 39.34% |
| Institutional Ownership | 74.11% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -6.97 |
| P/B | 2.66 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $78.44 |
Technical Indicators
| SMA20 | $33.23 |
| SMA50 | $30.64 |
| SMA200 | $24.70 |
| RSI | 51.38 |
| ATR | 2.8129 |
| Shares Float | 11.23M |
| Short Float | 23.77% |
| Short Ratio | 15.21 |
| Volatility | 0.10 |
| Rel Volume | 1.31 |
Performance History
| Week | -5.15% |
| Month | +8.63% |
| Quarter | +9.84% |
| 6 Months | +65.73% |
| YTD | +55.91% |
| Year | +44.44% |
| 3 Years | +89.98% |
| 5 Years | -68.92% |
| 10 Years | -91.29% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $32.60 | 277,608 |
| 2026-07-16 | $30.65 | 162,800 |
| 2026-07-15 | $32.50 | 240,900 |
| 2026-07-14 | $34.81 | 266,100 |
| 2026-07-13 | $34.34 | 150,100 |
| 2026-07-10 | $34.37 | 100,600 |
| 2026-07-09 | $35.27 | 216,200 |
| 2026-07-08 | $35.48 | 279,700 |
| 2026-07-07 | $36.54 | 365,000 |
| 2026-07-06 | $35.22 | 244,500 |
| 2026-07-02 | $37.93 | 478,500 |
| 2026-07-01 | $32.74 | 231,700 |
| 2026-06-30 | $34.38 | 193,600 |
| 2026-06-29 | $33.09 | 256,800 |
| 2026-06-26 | $31.99 | 307,200 |
| 2026-06-25 | $31.03 | 80,000 |
| 2026-06-24 | $30.72 | 95,800 |
| 2026-06-23 | $30.59 | 86,300 |
| 2026-06-22 | $30.34 | 106,800 |
| 2026-06-18 | $30.02 | 106,700 |
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
đ° Latest News
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. âĸ 2026-05-01T14:24:34Z
Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins
MarketBeat âĸ 2026-02-25T09:18:18Z
Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic
Simply Wall St. âĸ 2026-02-14T12:00:09Z
Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating
Insider Monkey âĸ 2025-12-10T19:13:08Z
Bullish Tectonic Therapeutic Insiders Loaded Up On US$61.2m Of Stock
Simply Wall St. âĸ 2025-10-12T13:26:18Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $63,000 | $107,000 | $152,000 | $144,000 |
| Total Expenses | $84,036,000 | $58,015,000 | $44,648,000 | $32,830,000 |
| Other Income Expense | $-119,000 | $-4,121,000 | $1,396,000 | $645,000 |
| Other Non Operating Income Expenses | $-119,000 | $-511,000 | $141,000 | $2,000 |
| Net Non Operating Interest Income Expense | $11,234,000 | $4,154,000 | $429,000 | $5,000 |
| Interest Expense Non Operating | $63,000 | $107,000 | $152,000 | $144,000 |
| Operating Expense | $84,036,000 | $58,015,000 | $44,648,000 | $32,830,000 |
| General And Administrative Expense | $20,547,000 | $16,651,000 | $7,682,000 | $7,176,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Net Interest Income | $11,234,000 | $4,154,000 | $429,000 | $5,000 |
| Interest Income | $11,297,000 | $4,261,000 | $581,000 | $149,000 |
| Normalized Income | $-74,151,000 | $-54,372,000 | $-44,078,000 | $-32,823,000 |
| Net Income From Continuing And Discontinued Operation | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Total Operating Income As Reported | $-84,036,000 | $-58,015,000 | $-44,648,000 | $-32,830,000 |
| Net Income Common Stockholders | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Net Income | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Net Income Including Noncontrolling Interests | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Net Income Continuous Operations | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Pretax Income | $-72,921,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Interest Income Non Operating | $11,297,000 | $4,261,000 | $581,000 | $149,000 |
| Operating Income | $-84,036,000 | $-58,015,000 | $-44,648,000 | $-32,830,000 |
| Per Share | ||||
| Diluted EPS | $-4.05 | $-6.83 | $-2.91 | $-2.18 |
| Basic EPS | $-4.05 | $-6.83 | $-2.91 | $-2.18 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-71,483,000 | $-52,620,000 | $-42,448,000 | $-31,673,000 |
| Reconciled Depreciation | $1,375,000 | $1,645,000 | $1,478,000 | $1,006,000 |
| EBITDA (Bullshit earnings) | $-71,483,000 | $-56,230,000 | $-41,193,000 | $-31,030,000 |
| EBIT | $-72,858,000 | $-57,875,000 | $-42,671,000 | $-32,036,000 |
| Diluted Average Shares | $18,322,533 | $8,490,171 | $14,734,323 | $14,734,323 |
| Basic Average Shares | $18,322,533 | $8,490,171 | $14,734,323 | $14,734,323 |
| Diluted NI Availto Com Stockholders | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Tax Provision | $1,230,000 | $0 | - | - |
| Research And Development | $63,489,000 | $41,364,000 | $36,966,000 | $25,654,000 |
| Selling General And Administration | $20,547,000 | $16,651,000 | $7,682,000 | $7,176,000 |
| Other Gand A | $8,997,000 | $8,789,000 | $3,738,000 | $3,239,000 |
| Salaries And Wages | $11,550,000 | $7,862,000 | $3,944,000 | $3,937,000 |
| Total Unusual Items | - | $-3,610,000 | $1,255,000 | $643,000 |
| Total Unusual Items Excluding Goodwill | - | $-3,610,000 | $1,255,000 | $643,000 |
| Gain On Sale Of Security | - | $-3,610,000 | $1,255,000 | $643,000 |
Fetched: 2026-07-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Total Assets | $261,038,000 | $152,905,000 | $39,399,000 | $47,209,000 |
| Total Non Current Assets | $3,679,000 | $6,048,000 | $8,515,000 | $10,167,000 |
| Other Non Current Assets | $1,125,000 | $743,000 | $618,000 | $613,000 |
| Current Assets | $257,359,000 | $146,857,000 | $30,884,000 | $37,042,000 |
| Other Current Assets | $2,974,000 | $5,618,000 | $2,115,000 | $1,076,000 |
| Restricted Cash | $587,000 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $253,798,000 | $141,239,000 | $28,769,000 | $35,966,000 |
| Cash And Cash Equivalents | $253,798,000 | $141,239,000 | $28,769,000 | $35,966,000 |
| Non Current Deferred Assets | - | $0 | $669,000 | - |
| Debt | ||||
| Total Debt | $1,276,000 | $3,303,000 | $4,343,000 | $5,792,000 |
| Long Term Debt And Capital Lease Obligation | $43,000 | $519,000 | $2,520,000 | $4,343,000 |
| Current Debt And Capital Lease Obligation | $1,233,000 | $2,784,000 | $1,823,000 | $1,449,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $9,709,000 | $12,129,000 | $124,035,000 | $92,863,000 |
| Total Non Current Liabilities Net Minority Interest | $43,000 | $519,000 | $83,147,000 | $85,026,000 |
| Current Liabilities | $9,666,000 | $11,610,000 | $40,888,000 | $7,837,000 |
| Payables And Accrued Expenses | $4,323,000 | $5,241,000 | $5,694,000 | $3,731,000 |
| Payables | $1,093,000 | $976,000 | $409,000 | $574,000 |
| Accounts Payable | $1,093,000 | $976,000 | $409,000 | $574,000 |
| Other Current Liabilities | - | - | $30,515,000 | $499,000 |
| Other Non Current Liabilities | - | - | - | $56,000 |
| Non Current Deferred Liabilities | - | - | - | $0 |
| Current Deferred Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Total Equity Gross Minority Interest | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Stockholders Equity | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Gains Losses Not Affecting Retained Earnings | $-96,000 | $9,000 | $-11,000 | - |
| Other Equity Adjustments | $-96,000 | $9,000 | $-11,000 | - |
| Retained Earnings | $-222,737,000 | $-148,586,000 | $-90,604,000 | $-47,781,000 |
| Preferred Securities Outside Stock Equity | - | $0 | $80,627,000 | $80,627,000 |
| Other | ||||
| Ordinary Shares Number | $18,738,249 | $14,856,309 | $14,734,323 | $14,734,323 |
| Share Issued | $18,738,249 | $14,856,309 | $14,734,323 | $14,734,323 |
| Tangible Book Value | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Invested Capital | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Working Capital | $247,693,000 | $135,247,000 | $-10,004,000 | $29,205,000 |
| Capital Lease Obligations | $1,276,000 | $3,303,000 | $4,343,000 | $5,792,000 |
| Total Capitalization | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Additional Paid In Capital | $474,160,000 | $289,351,000 | $5,979,000 | $2,127,000 |
| Capital Stock | $2,000 | $2,000 | $0 | $0 |
| Common Stock | $2,000 | $2,000 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | - |
| Long Term Capital Lease Obligation | $43,000 | $519,000 | $2,520,000 | $4,343,000 |
| Current Capital Lease Obligation | $1,233,000 | $2,784,000 | $1,823,000 | $1,449,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,110,000 | $3,585,000 | $2,856,000 | $2,158,000 |
| Current Accrued Expenses | $3,230,000 | $4,265,000 | $5,285,000 | $3,157,000 |
| Net PPE | $2,554,000 | $5,305,000 | $7,228,000 | $9,554,000 |
| Accumulated Depreciation | $-3,407,000 | $-2,745,000 | $-1,856,000 | $-877,000 |
| Gross PPE | $5,961,000 | $8,050,000 | $9,084,000 | $10,431,000 |
| Leases | $25,000 | $25,000 | $25,000 | $25,000 |
| Other Properties | $5,655,000 | $7,744,000 | $8,616,000 | $9,964,000 |
| Machinery Furniture Equipment | $281,000 | $281,000 | $405,000 | $393,000 |
| Properties | $0 | $0 | $0 | $0 |
| Construction In Progress | - | $0 | $38,000 | $49,000 |
Fetched: 2026-07-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-60,286,000 | $-59,236,000 | $-40,960,000 | $-29,725,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-60,078,000 | $-59,080,000 | $-40,681,000 | $-27,637,000 |
| Cash Flow From Continuing Operating Activities | $-60,078,000 | $-59,080,000 | $-40,681,000 | $-27,637,000 |
| Operating Gains Losses | $153,000 | - | $264,000 | $-643,000 |
| Investing Activities | ||||
| Capital Expenditure | $-208,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Investing Cash Flow | $-138,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Cash Flow From Continuing Investing Activities | $-138,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $173,098,000 | $94,600,000 | $34,125,000 | $38,017,000 |
| Financing Cash Flow | $173,355,000 | $171,714,000 | $33,747,000 | $37,628,000 |
| Cash Flow From Continuing Financing Activities | $173,355,000 | $171,714,000 | $33,747,000 | $37,628,000 |
| Net Other Financing Charges | $-485,000 | $75,965,000 | - | - |
| Net Common Stock Issuance | $173,098,000 | $94,600,000 | $34,125,000 | - |
| Common Stock Issuance | $173,098,000 | $94,600,000 | $34,125,000 | - |
| Net Preferred Stock Issuance | - | - | - | $38,017,000 |
| Preferred Stock Issuance | - | - | - | $38,017,000 |
| Other | ||||
| Repayment Of Debt | $-489,000 | $-475,000 | $-499,000 | $-393,000 |
| Interest Paid Supplemental Data | $63,000 | $107,000 | $152,000 | $144,000 |
| End Cash Position | $254,870,000 | $141,826,000 | $29,356,000 | $36,553,000 |
| Beginning Cash Position | $141,826,000 | $29,356,000 | $36,553,000 | $28,650,000 |
| Effect Of Exchange Rate Changes | $-95,000 | $-8,000 | $16,000 | - |
| Changes In Cash | $113,139,000 | $112,478,000 | $-7,213,000 | $7,903,000 |
| Proceeds From Stock Option Exercised | $1,231,000 | $1,624,000 | $121,000 | $4,000 |
| Net Issuance Payments Of Debt | $-489,000 | $-475,000 | $-499,000 | $-393,000 |
| Net Long Term Debt Issuance | $-489,000 | $-475,000 | $-499,000 | $-393,000 |
| Long Term Debt Payments | $-489,000 | $-475,000 | $-499,000 | $-393,000 |
| Net PPE Purchase And Sale | $-138,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Sale Of PPE | $70,000 | $0 | - | - |
| Purchase Of PPE | $-208,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Change In Working Capital | $-70,000 | $-10,278,000 | $-584,000 | $1,836,000 |
| Change In Other Current Liabilities | $-2,295,000 | $-565,000 | $-1,006,000 | $-1,049,000 |
| Change In Other Current Assets | $17,000 | $544,000 | $-5,000 | $-14,000 |
| Change In Payables And Accrued Expense | $-436,000 | $-7,063,000 | $1,446,000 | $3,275,000 |
| Change In Accrued Expense | $-552,000 | $-5,642,000 | $1,611,000 | $4,509,000 |
| Change In Payable | $116,000 | $-1,421,000 | $-165,000 | $-1,234,000 |
| Change In Account Payable | $116,000 | $-1,421,000 | $-165,000 | $-1,234,000 |
| Change In Prepaid Assets | $2,644,000 | $-3,194,000 | $-1,019,000 | $-376,000 |
| Other Non Cash Items | $2,118,000 | $4,044,000 | $-137,000 | $1,225,000 |
| Stock Based Compensation | $10,497,000 | $3,491,000 | $1,121,000 | $1,119,000 |
| Depreciation Amortization Depletion | $1,375,000 | $1,645,000 | $1,478,000 | $1,006,000 |
| Depreciation And Amortization | $1,375,000 | $1,645,000 | $1,478,000 | $1,006,000 |
| Gain Loss On Sale Of PPE | $153,000 | $0 | $9,000 | - |
| Net Income From Continuing Operations | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Gain Loss On Sale Of Business | - | $0 | $255,000 | - |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | $-643,000 |
Fetched: 2026-07-15